Kevin S. Sr. Boyle - Aug 30, 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role: Chief Executive Officer, Director
Signature: /s/ Timothy Cunningham, Attorney-in-Fact
Stock symbol: TCRT
Transactions as of: Aug 30, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/31/2021, 04:42 PM
Next filing: Nov 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCRT	Common Stock	Award	$0	+875K		$0.00	875K	Aug 30, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRT	Employee Stock Option (right to buy)	Award	$0	+2.63M		$0.00	2.63M	Aug 30, 2021	Common Stock	2.63M	$1.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-fourth of the shares vest on each of August 30, 2022, August 30, 2023, August 30, 2024 and August 30, 2025, subject to the Reporting Person's continued service through each such date.
F2	One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three month after 8/30/2021, subject to the Reporting Person's continued service through each such date.